CTSOVSHAE• 3 Months (Normalized)
CTSO vs HAE (Cytosorbents Corporation vs Haemonetics Corporation)
Showing Closing Date Range from Jul 8 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CTSO Performance $3.96
+915.38%
Cytosorbents Corporation
Normalized Baseline0.00%
HAE Performance $103.52
+40.23%
Haemonetics Corporation
Normalized Baseline0.00%
Alpha Spread Margin CTSO LEADS
+875.15 pts
CTSO outperforming by 875.15 percentage points
CTSOHAE
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CTSO HAE
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(64 dates)
| Date | CTSO Price | CTSO Gain (%) | HAE Price | HAE Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $3.96 | +915.38% | $103.52 | +40.23% | +875.15% |
| Oct 05, 2026 | $3.97 | +916.67% | $104.68 | +41.80% | +874.87% |
| Oct 02, 2026 | $4.05 | +938.46% | $104.68 | +41.80% | +896.66% |
| Oct 01, 2026 | $- | $104.37 | +41.38% | - | |
| Sep 30, 2026 | $3.90 | +900.00% | $105.30 | +42.64% | +857.36% |
| Sep 29, 2026 | $4.00 | +925.64% | $105.80 | +43.32% | +882.32% |
| Sep 28, 2026 | $4.02 | +930.77% | $105.79 | +43.31% | +887.46% |
| Sep 25, 2026 | $4.38 | +1023.08% | $105.30 | +42.64% | +980.44% |
| Sep 24, 2026 | $4.30 | +1002.56% | $- | - | |
| Sep 23, 2026 | $4.91 | +1158.97% | $106.82 | +44.70% | +1114.27% |
| Sep 22, 2026 | $- | $108.52 | +47.01% | - | |
| Sep 21, 2026 | $5.51 | +1312.82% | $108.73 | +47.29% | +1265.53% |
| Sep 18, 2026 | $5.75 | +1374.36% | $108.40 | +46.84% | +1327.52% |
| Sep 17, 2026 | $5.76 | +1376.92% | $107.60 | +45.76% | +1331.16% |
| Sep 16, 2026 | $5.73 | +1369.23% | $106.24 | +43.92% | +1325.31% |
Page 1 of 5